Inspire Medical Systems, Inc.
$1.63B- Market cap
- $1.82B
- Debt
- +$112.36M
- Cash
- −$308.27M
Capital structure 94% equity / 6% debt · EV / Revenue 1.78x · EV / EBITDA 24.73x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: INSP stock price vs OSCR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OSCR's multiple
Needs OSCR P/E.
Implied fair value · at INSP's multiple
Needs EPS (TTM) is negative, INSP P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INSP FY 2025 (ended Dec 31, 2025) · OSCR FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 1.78x · EV / EBITDA 24.73x
Capital structure 96% equity / 4% debt · EV / Revenue 0.63x
OSCR carries the larger enterprise value at $7.34B against $1.63B; OSCR trades on the lower EV / Revenue multiple (0.63x vs 1.78x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Inspire Medical Systems, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Oscar Health, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.14x
0.44x
Net debt / EBITDA
Leverage against operating earnings
-2.98x
5.54x
Cash and equivalents
Liquid reserves on the balance sheet
$308.27M
$2.77B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BOSTON SCIENTIFIC CORP
INSP vs BSX
Medtronic plc
INSP vs MDT
ABBOTT LABORATORIES
INSP vs ABT
JOHNSON & JOHNSON
INSP vs JNJ
LivaNova PLC
INSP vs LIVN
Cigna Group
INSP vs CI
CENTENE CORP
INSP vs CNC
Elevance Health, Inc.
INSP vs ELV
HUMANA INC
INSP vs HUM
UNITEDHEALTH GROUP INC
INSP vs UNH
$112.36M
$430.10M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.